Colchicine, a long-established anti-inflammatory agent primarily used in gout and pericarditis, has been repurposed as a potential therapy against COVID-19. Its mechanism of action centres on ...
Researchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and ...
About The Study: In this randomized clinical trial, among adults with long COVID, colchicine did not improve functional capacity, respiratory function, or inflammatory markers. These findings ...
Nov 27 (Reuters) - Colchicine, a commonly used anti-inflammatory drug, will be investigated as a possible treatment for COVID-19 in the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial, the ...
Colchicine is a generic prescription medication used to prevent gout flares and treat familial Mediterranean fever (FMF) in adults and certain children. Like most drugs, colchicine can cause side ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results